Immunicum Announces Results of Directed Share Issue
June 17, 2021 16:20 ET | Immunicum AB
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR THE UNITED STATES OF AMERICA,...
Immunicum offentliggör utfallet av riktad emission av aktier
June 17, 2021 16:20 ET | Immunicum AB
EJ FÖR PUBLICERING, DISTRIBUTION ELLER OFFENTLIGGÖRANDE, DIREKT ELLER INDIREKT, INOM ELLER TILL AUSTRALIEN, HONGKONG, KANADA, JAPAN, NYA ZEELAND, SCHWEIZ SINGAPORE, SYDAFRIKA ELLER USA ELLER NÅGON...
Immunicum Announces its Intention to Carry Out a Directed Share Issue
June 17, 2021 11:31 ET | Immunicum AB
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR THE UNITED STATES OF AMERICA,...
Immunicum offentliggör avsikt att genomföra en riktad emission av aktier
June 17, 2021 11:31 ET | Immunicum AB
EJ FÖR PUBLICERING, DISTRIBUTION ELLER OFFENTLIGGÖRANDE, DIREKT ELLER INDIREKT, INOM ELLER TILL AUSTRALIEN, HONGKONG, KANADA, JAPAN, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA ELLER USA ELLER NÅGON...
Teneo_logo_FINAL_whitebkgnd.png
Teneobio’s Clinical Candidate, TNB-409, is a Selective IL-2 Receptor Bispecific Agonist for the Treatment of Solid Tumors
May 19, 2021 08:00 ET | TeneoBio, Inc
NEWARK, Calif., May 19, 2021 (GLOBE NEWSWIRE) -- Teneobio, Inc., a clinical stage biotech company focused on the discovery and development of novel multi-specific biotherapeutic antibodies,...
FStar.jpg
F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 17, 2021 08:00 ET | F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., May 17, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...
Logo.jpg
Celsion Corporation Reports First Quarter 2021 Financial Results and Provides Business Update
May 14, 2021 08:00 ET | Celsion CORP
Focus on Immuno-Oncology and Next-Generation Vaccines is Supported with a Strong Balance Sheet Conference Call Begins at 10:00 a.m. Eastern Time Today LAWRENCEVILLE, N.J., May 14,...
Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:02 ET | Immunicum AB
Press Release 12 May 2021 Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) today announced that it will be...
Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:02 ET | Immunicum AB
Pressrelease 12 maj 2021 Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) tillkännagav idag att bolaget kommer att...
LOGO.png
Autolus Therapeutics to Present New Data on AUTO1 in r/r Indolent B Cell Lymphomas at the European Hematology Association Virtual Congress
May 12, 2021 10:00 ET | Autolus Therapeutics plc
AUTO1 achieves 100% complete remission rate in cohort of r/r Indolent Non- Hodgkin Lymphoma patients No high-grade cytokine release syndrome or neurotoxicity observed LONDON, May 12, 2021 ...